文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤微环境影响抗癌药物的活性与递送:药理学与化学的交融

Tumor Niche Influences the Activity and Delivery of Anticancer Drugs: Pharmacology Meets Chemistry.

作者信息

Ravera Mauro, Gabano Elisabetta, Tonello Stelvio, Colangelo Donato

机构信息

Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale Teresa Michel 11, 15121 Alessandria, Italy.

Dipartimento per lo Sviluppo Sostenibile e la Transizione Ecologica, Università del Piemonte Orientale, Piazza Sant'Eusebio 5, 13100 Vercelli, Italy.

出版信息

Pharmaceuticals (Basel). 2025 Jul 17;18(7):1047. doi: 10.3390/ph18071047.


DOI:10.3390/ph18071047
PMID:40732334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12298015/
Abstract

Cellular and molecular characteristics of the tumor microenvironment are fundamental for the formation of niches. These structures include both cellular and matrix components and have been shown to protect and promote cancer formation and progression. The peculiarities of tumor niches have been suggested by many authors as targets with high therapeutic potential. This narrative review analyzes the chemical characteristics of the tumor microenvironment and describes experimental and clinical approaches to influence its contribution to cancer promotion and the spread of metastases. In particular, the possible chemical differences, like pH, oxygen levels, and cell composition, to be used for the design of drugs or the delivery of antiproliferative moieties for a more precise oncology approach, will be discussed. The literature proposes a vast number of molecules, but this review focuses on hypoxia-activated molecules, pH-sensitive nanocarriers, metal-based drugs, and gasotransmitters targeting selectively the tumor microenvironment as possible negative modulators of the contribution of niches to tumor promotion. The chemical peculiarities of the tumor niche are discussed for possible pharmacological developments.

摘要

肿瘤微环境的细胞和分子特征是龛形成的基础。这些结构包括细胞和基质成分,并且已被证明可保护和促进癌症的形成与进展。许多作者认为肿瘤龛的特性是具有高治疗潜力的靶点。本叙述性综述分析了肿瘤微环境的化学特征,并描述了影响其对癌症促进和转移扩散作用的实验和临床方法。特别是,将讨论可能用于设计药物或递送抗增殖部分以实现更精确肿瘤学方法的化学差异,如pH值、氧水平和细胞组成。文献中提出了大量分子,但本综述重点关注缺氧激活分子、pH敏感纳米载体、金属基药物和气体信号分子,它们作为龛对肿瘤促进作用的可能负调节剂,选择性地靶向肿瘤微环境。讨论了肿瘤龛的化学特性以促进可能的药理学发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/5ed085414cca/pharmaceuticals-18-01047-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/a81e1831479f/pharmaceuticals-18-01047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/74ffe32638f6/pharmaceuticals-18-01047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/c1b34c550bb0/pharmaceuticals-18-01047-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/718b83615331/pharmaceuticals-18-01047-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/5419e3d6f9cf/pharmaceuticals-18-01047-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/5ed085414cca/pharmaceuticals-18-01047-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/a81e1831479f/pharmaceuticals-18-01047-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/74ffe32638f6/pharmaceuticals-18-01047-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/c1b34c550bb0/pharmaceuticals-18-01047-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/718b83615331/pharmaceuticals-18-01047-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/5419e3d6f9cf/pharmaceuticals-18-01047-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8168/12298015/5ed085414cca/pharmaceuticals-18-01047-g006.jpg

相似文献

[1]
Tumor Niche Influences the Activity and Delivery of Anticancer Drugs: Pharmacology Meets Chemistry.

Pharmaceuticals (Basel). 2025-7-17

[2]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[3]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[4]
The Black Book of Psychotropic Dosing and Monitoring.

Psychopharmacol Bull. 2024-7-8

[5]
Short-Term Memory Impairment

2025-1

[6]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[7]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[8]
[Research progress of peptide recognition-guided strategies for exosome isolation and enrichment].

Se Pu. 2025-5

[9]
Microenvironment and Tumor Heterogeneity as Pharmacological Targets in Precision Oncology.

Pharmaceuticals (Basel). 2025-6-18

[10]
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Cochrane Database Syst Rev. 2015-9-29

本文引用的文献

[1]
A dual-targeting strategy to inhibit colorectal cancer liver metastasis via tumor cell ferroptosis and cancer-associated fibroblast reprogramming.

Bioact Mater. 2025-6-5

[2]
Biomimetic nanoplatforms for combined DDR2 inhibition and photothermal therapy in dense breast cancer treatment.

Biomaterials. 2026-1

[3]
A TME-responsive oxygen-self-supplying hybridized polymersome for synergistic triple-modal therapy and precision theranostics in hypoxic tumors.

J Mater Chem B. 2025-7-10

[4]
Targeted Lung Premetastasis Niche: Mechanisms, Strategies, and Application.

MedComm (2020). 2025-6-3

[5]
Decoding the Metabolic-immune Axis: Neutrophil glycolysis-driven tumor niche remodeling and its therapeutic exploitation.

Pharmacol Res. 2025-7

[6]
Targeting platelet-tumor cell interactions: a novel approach to cancer therapy.

Med Oncol. 2025-6-2

[7]
The Role of Tregs in the Tumor Microenvironment.

Biomedicines. 2025-5-11

[8]
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept study.

Front Oncol. 2025-4-25

[9]
CanSeer: a translational methodology for developing personalized cancer models and therapeutics.

Sci Rep. 2025-4-29

[10]
High-precision information retrieval for rapid clinical guideline updates.

NPJ Digit Med. 2025-4-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索